Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease

Recruiting now

Conditions studied: Glycogen Storage Disease Type IA, Glycogen Storage Disease Type I, Glycogen Storage Disease Type IB, Glycogen Storage Disease Xi

In brief

The goal of this study is to determine if the Lactate Plus meter is accurate compared to lab lactate levels, and to determine if the Accu chek guide glucometer is accurate compared to lab serum glucose levels in patients with Glycogen Storage Disease Types Ia, Ib and XI. To determine this, patient's will have a one-time planned admission to Connecticut Children's for approximately 8 hours and receive hourly blood draws as well as finger-sticks.

Key facts

Study ID

NCT07459582

Run by

Connecticut Children's Medical Center

People needed

10

Starts

2026-08-01

Expected to finish

2027-12-01

Last updated by the study team

2026-06-01

Who can join

Age: any, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with diagnosed/confirmed (by liver biopsy or genetic testing) Glycogen Storage Disease Type Ia/Ib (ICD 10 code: E74.01) or XI (74.09).
• For pediatric participants: Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document
• For adolescents: assent to participate
• For adults: Ability to understand and the willingness to sign a written informed consent

You may not qualify if…

• Patients with Glycogen storage disease unspecified
• Patients not meeting inclusion criteria
• Patients unable to provide consent
• Patients who decline to be in the study

Where it is running

• Connecticut Children's — Hartford, Connecticut, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.